Keros Therapeutics, Inc. (KROS)

Keros Therapeutics Revenue

In the year 2024, Keros Therapeutics had annual revenue of $3.55M with 2,250.99% growth. Keros Therapeutics had revenue of $3.04M in the quarter ending December 31, 2024, with 2,027.27% growth.

• Revenue (ttm): $3.55M
• Revenue Growth: +2,250.99%
• P/S Ratio: 113.79
• Revenue / Employee: $21,006
• Employees: 169
• Market Cap: 401.17M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	3.55M	3.40M	2,250.99%
Dec 31, 2023	151.00K	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	20.10M	-	-
Dec 31, 2020	-	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.